Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -2.848% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CCC(=O)Nc1nonc1-c1nc2ccccc2n1CC(C)C
b) CCOC(=O)Cn1c(=O)oc2cc(S(=O)(=O)Nc3ccc(F)cc3)ccc21
Answer: a. CCC(=O)Nc1nonc1-c1nc2ccccc2n1CC(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1nonc1-c1nc2ccccc2n1CC(C)C
CCC(=O)Nc1nonc1-c1nc2ccccc2n1CC(C)C
N-[4-[1-(2-methylpropyl)benzimidazol-2-yl]-1,2,5-oxadiazol-3-yl]propanamide